| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| (N-Me-Tyr1,N-Me-Arg7,D-Leu-NHEt8)-Dynorphin A (1-8) |
|
103613-84-9 |
詳細(xì)
|
| Thymalfasin |
|
69440-99-9 |
詳細(xì)
|
| NOTA-NOC |
|
|
詳細(xì)
|
| Cyclo(-Arg-Ala-Asp-D-Phe-Cys) |
|
1055991-02-0 |
詳細(xì)
|
| (Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH |
|
148029-26-9 |
詳細(xì)
|
| Hynic-[Tyr3]Octreotide, |
|
257943-19-4 |
詳細(xì)
|
| PSMA-ligand- 1 |
|
1610413-97-2 |
詳細(xì)
|
| PSMA- 11 |
|
1366302-52-4 |
詳細(xì)
|
| Ac-Ile-Glu-Thr-Asp-aldehyde |
|
191338-86-0 |
詳細(xì)
|
| Suc-Ala-Ala-Pro-Lys-pNA |
|
108929-39-1 |
詳細(xì)
|
| Corticotropin |
|
9002-60-2 |
詳細(xì)
|
| (D-His2,D-Ser(tBu)6,Azagly10)-LHRH |
|
1926163-37-2 |
詳細(xì)
|
| NOTA-Octreotide |
|
|
詳細(xì)
|
| PSMA- 1007 |
|
|
詳細(xì)
|
| H-Lys-Thr-Tyr-OH |
|
108191-44-2 |
詳細(xì)
|
| NOTA-TATE |
|
|
詳細(xì)
|
| DeslorelinAcetate |
|
57773-65-6 |
詳細(xì)
|
| (D-Ser(tBu)6,Azagly10)-LHRH |
|
145781-92-6 |
詳細(xì)
|
| Glucagon-likepeptideI |
|
107444-51-9 |
詳細(xì)
|
| M2e, human |
|
251359-24-7 |
詳細(xì)
|
| PSMA-617 |
|
1702967-37-0 |
詳細(xì)
|
| FAPI04;FAPI-4;FAPI 4;FAPI |
|
2374782-02-0 |
詳細(xì)
|
| G-V-L-S-N-V-I-G-Y-L-K-K-L-G-T-G-A-L-N-A-V-L-K-Q |
|
136831-50-0 |
詳細(xì)
|
| Albenatide |
|
1031700-39-6 |
詳細(xì)
|
| Fmoc-Cys(Trt)-OH |
|
103213-32-7 |
詳細(xì)
|
| Trofinetide |
|
853400-76-7 |
詳細(xì)
|
| (β-Ala70)-C3a (70-77) |
|
105931-71-3 |
詳細(xì)
|
| (S)-5-tert-butoxy-4-(3-((S)- 1,5-di-tert-butoxy- 1,5- dioxopentan-2-yl)ureido)-5-oxopentanoic acid |
|
1026987-94-9 |
詳細(xì)
|
| NTFAPI, (S)-2,2'-(7-(2-(4-(3-((4-((2-(2-cyano-4,4- difluoropyrrolidin- 1-yl)-2-oxoethyl)carbamoyl)quinolin-6- yl)oxy)propyl)piperazin- 1-yl)-2-oxoethyl)- 1,4,7-triazonane- 1,4- diyl)diacetic acid |
|
2374782-03-1 |
詳細(xì)
|
| DOTA-TATE, DOTA-[Tyr3]-Octreotate |
|
177943-88-3 |
詳細(xì)
|
| 4,5-dihydro-5,5-dimethyl-3-isoxazolyl Carbamimidothioic acid ester hydrochloride (1:1) |
|
869002-97-1 |
詳細(xì)
|
| MeOSuc-Ala-Ala-Pro-Val-OH |
|
107441-48-5 |
詳細(xì)
|
| Tyr-CRF (human, rat) |
|
100513-58-4 |
詳細(xì)
|
| Pemvidutide |
|
2538014-94-5 |
詳細(xì)
|
| Pyroglutamyl-histidyl-tryptophyl-seryl-tyrosyl methyl ester |
|
51871-39-7 |
詳細(xì)
|
| SH-FAPI-4, (S)-N-(2-(2-cyano-4,4-difluoropyrrolidin- 1-yl)- 2-oxoethyl)-6-(3-(4-(3-mercaptopropanoyl)piperazin- 1- yl)propoxy)quinoline-4-carboxamide |
|
|
詳細(xì)
|
| Boc-Leu-Arg-Arg-AMC |
|
109358-46-5 |
詳細(xì)
|
| Lecirelin(Dalmarelin)Acetate |
|
61012-19-9 |
詳細(xì)
|
| Epidermal growth factor (EGF) |
|
62253-63-8 |
詳細(xì)
|
| (S)-Di-Tert-Butyl 2-(3-((S)-6-Amino- 1-(Tert-Butoxy)- 1- Oxohexan-2-Yl)Ureido)Pentanedioate |
|
1025796-31-9 |
詳細(xì)
|
| (D-Ser(tBu)6,D-Leu7,Azagly10)-LHRH |
|
1926163-38-3 |
詳細(xì)
|
| Pefachrome tPA |
|
161572-29-8 |
詳細(xì)
|
| Gly-Val-Ser-Trp-Gly-Leu-Arg |
|
1801959-12-5 |
詳細(xì)
|
| Antipain |
|
37691-11-5 |
詳細(xì)
|
| Acetyl Tetrapeptide-40 |
|
1472633-28-5 |
詳細(xì)
|
| 2-METHYL-4-(TRIFLUOROMETHYL)-1,3-THIAZOLE-5-CARBOXYLIC ACID |
|
117724-63-7 |
詳細(xì)
|
| PT141Acetate/BremelanotideAcetate |
|
32780-32-8 |
詳細(xì)
|
| H-Leu-Ala-Ala-Val-Ser-Asp-Leu-Asn-Pro-Asn-Ala-Pro-Arg-OH |
|
415684-36-5 |
詳細(xì)
|
| NH2-UAMC1110 |
|
|
詳細(xì)
|
| Obestatin,rat,mouse |
|
869705-22-6 |
詳細(xì)
|
| SplenopentinAcetate |
|
105184-37-0 |
詳細(xì)
|
| Pardaxin |
|
67995-63-5 |
詳細(xì)
|
| CALP1 |
|
145224-99-3 |
詳細(xì)
|
| Huwentoxin IV |
|
526224-73-7 |
詳細(xì)
|
| B7-33 |
|
|
詳細(xì)
|
| Pentixafor |
|
1341207-62-2 |
詳細(xì)
|
| Suc-Ala-Ala-Pro-Glu-pNA |
|
108929-37-9 |
詳細(xì)
|
| (D-Ser4)-LHRH |
|
103065-82-3 |
詳細(xì)
|
| (Des-Gly10,D-Ser(tBu)6,Pro-NHNH)-LHRH |
|
147688-42-4 |
詳細(xì)
|
| Biotinyl-CRF (human, rat) |
|
105883-79-2 |
詳細(xì)
|
| Dolastatin 10 |
|
110417-88-4 |
詳細(xì)
|
| (Des-Gly10,D-Ser4,D-Leu6,Pro-NHEt9)-LHRH |
|
62621-13-0 |
詳細(xì)
|
| H-Met-Gly-Gly-OH |
|
14486-02-3 |
詳細(xì)
|
| Z-Phe-Leu-Glu-pNA |
|
104634-10-8 |
詳細(xì)
|
| (D-Ala2,N-Me-Phe4,glycinol5)-Enkephalin |
|
100929-53-1 |
詳細(xì)
|
| H-Gly-D-Val-OH |
|
10521-49-0 |
詳細(xì)
|
| H-Met-Phe-OH |
|
14492-14-9 |
詳細(xì)
|
| Kinetensin |
|
103131-69-7 |
詳細(xì)
|
| Ac-Ala-Ala-Ala-OH |
|
19245-85-3 |
詳細(xì)
|
| Dynorphin B |
|
83335-41-5 |
詳細(xì)
|
| PSMA-617 linker, Vipivotide tetraxetan Linker, (10S, 14S)- 1- (4-(aminomethyl)cyclohexyl)-3-(naphthalen-2-ylmethyl)- 1,4, 12-trioxo- 2,5, 11, 13-tetraazahexadecane- 10, 14, 16-tricarboxylic acid |
|
1703768-74-4 |
詳細(xì)
|
| BVD 10 |
|
262418-00-8 |
詳細(xì)
|
| 4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-4,4-difluoro- 1-pyrrolidinyl]-2-oxoethyl]-6-[3-(1-piperazinyl)propoxy]- |
|
2471983-20-5 |
詳細(xì)
|
| DOTA-Octreotide |
|
|
詳細(xì)
|
| HYINC-FAPI-4 |
|
|
詳細(xì)
|
| ACTH(5-10) |
|
122249-41-6 |
詳細(xì)
|
| (D-Arg0,Hyp3,β-(2-thienyl)-Ala5·8,D-Phe7)-Bradykinin |
|
103412-36-8 |
詳細(xì)
|
| HBED-CC-tris |
|
|
詳細(xì)
|
| (Des-Gly10,D-Leu6,Orn8,Pro-NHEt9)-LHRH |
|
1051970-61-6 |
詳細(xì)
|
| (Des-Gly10,Ser(Ac)4,D-Leu6,Pro-NHEt9)-LHRH |
|
1926163-25-8 |
詳細(xì)
|
| H-Ala-Ala-Ala-Tyr-Ala-Ala-OH |
|
107865-42-9 |
詳細(xì)
|
| (Gln22)-Amyloid β-Protein (1-42) |
|
147335-12-4 |
詳細(xì)
|
| Amyloid β-Protein (25-35) amide |
|
147490-49-1 |
詳細(xì)
|
| Pyr-Gln-OH |
|
109481-23-4 |
詳細(xì)
|
| Ac-Val-Asp-Val-Ala-Asp-aldehyde |
|
194022-51-0 |
詳細(xì)
|
| Obestatin, human |
|
1081110-72-6 |
詳細(xì)
|
| (Des-Gly10,D-His(Bzl)6,Pro-NHEt9)-LHRH |
|
220810-26-4 |
詳細(xì)
|
| UAMC1110, (S)-N-(2-(2-cyano-4,4-difluoropyrrolidin- 1-yl)- 2-oxoethyl)quinoline-4-carboxamide |
|
1448440-52-5 |
詳細(xì)
|
| HistrelinAcetate |
|
76712-82-8 |
詳細(xì)
|
| Kaliotoxin |
|
145199-73-1 |
詳細(xì)
|
| Cyclo(L-Phe-L-Pro) |
|
3705-26-8 |
詳細(xì)
|
| Margatoxin |
|
145808-47-5 |
詳細(xì)
|
| H-Gly-Gly-Asp-Ala-OH |
|
103972-83-4 |
詳細(xì)
|
| Lipopeptide Acetate |
|
|
詳細(xì)
|
| AlarelinAcetate |
|
79561-22-1 |
詳細(xì)
|
| (D-Trp6)-LHRH (2-10) |
|
108787-46-8 |
詳細(xì)
|
| CTOP |
|
103429-31-8 |
詳細(xì)
|
| FAPI- 14 ,(S)-6-[3-(4-Boc- 1-piperazinyl)propoxy]-N-[2-(2- cyano-4,4-difluoro- 1-pyrrolidinyl)-2-oxoethyl]quinoline-4-carboxamide |
|
2374782-82-6 |
詳細(xì)
|
| F-PSMA 1007 |
|
2093321-18-5 |
詳細(xì)
|